The debate over GLP-1 receptor agonist drugs for weight loss intensifies in India amid reports of their growing misuse for cosmetic reasons. This comes as the pharmaceutical industry faces significant lawsuits in the West, with plaintiffs alleging that drugs like Ozempic have led to blindness. Experts on the program call for clear guidelines and guardrails from the health ministry to prevent dangerous, over-the-counter use, suggesting prescriptions be limited to specialists like endocrinologists. The discussion highlights that India faces a "triple burden of malnutrition," and lifestyle modifications should be the first line of defence against obesity. An expert stated that weight loss drugs and surgery "are not the solution, rather they are the last resort." A parallel is drawn to the overuse of antibiotics, raising concerns about the long-term consequences of these powerful new drugs. #weightloss #glp1 #obesity #itwebvideos #healthindia #drugsafety #ozempic #regulation #endocrinology #publichealth #misuse #sideeffects #weightlossjourney #india #healthcare #patientsafety
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
